Microvesicle removal of anticancer drugs contributes to drug resistance in human pancreatic cancer cells-Reference-Cited by-同舟云学术

Microvesicle removal of anticancer drugs contributes to drug resistance in human pancreatic cancer cells

Published:2016-07-04 Issue:31 Volume:7 Page:50365-50379
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Muralidharan-Chari Vandhana¹,Kohan Hamed Gilzad²,Asimakopoulos Alexandros G.³,Sudha Thangirala¹,Sell Stewart³,Kannan Kurunthachalam³,Boroujerdi Mehdi²,Davis Paul J.¹⁴,Mousa Shaker A.¹

Affiliation:

1. The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA

2. Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Albany, NY 12208, USA

3. Wadsworth Center, New York State Department of Health, and School of Public Health, University at Albany, Albany, NY 12201, USA

4. Department of Medicine, Albany Medical College, Albany, NY 12208, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilizing Extracellular Vesicles for Eliminating ‘Unwanted Molecules’: Harnessing Nature’s Structures in Modern Therapeutic Strategies;Molecules;2024-02-21

2. Exosome inhibition improves response to first‐line therapy in small cell lung cancer;Journal of Cellular and Molecular Medicine;2024-02

3. Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer;Seminars in Cancer Biology;2023-12

4. Exosomes in Cancer Progression and Therapy Resistance: Molecular Insights and Therapeutic Opportunities;Life;2023-10-09

5. Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance;Cancers;2023-09-25